Evidence map›Paper›PMID 40038231›Full record

ArticleJournal of clinical laboratory analysis2025

V-PRO Blood Collection Tubes: Validation for Clinical Chemistry and Immunoassay Tests.

Anwar Borai, Wedyan Alsharif, Amirah Alhindi, Maha Alqahtani, Mohieldin Elsayid, Haitham Khalil, Salwa Al Marwani, Abobaker Yagoot, Janet Magjacot, Maha Al Meteiri and 3 more

Abstract readValidation Study
In one paragraph

Article in Journal of clinical laboratory analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anwar BoraiKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0001-6504-9559
Wedyan AlsharifKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Amirah AlhindiKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Maha AlqahtaniKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Mohieldin ElsayidKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Haitham KhalilKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Salwa Al MarwaniKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Abobaker YagootKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Janet MagjacotKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Maha Al MeteiriKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Rawan AlyamaniKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
Hind AbdulhakimKing Fahad Armed Forces Hospital, Department of Pathology and Laboratory Medicine, Jeddah, Saudi Arabia.
Majid Al-ThaqafyKing Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0001-7989-1392

Funding

Becton Dickenson and Company
6 · The paper itself

Abstract

backgroundIn accredited laboratories, each component of diagnostic products-such as laboratory instruments, reagents, and blood collection tubes must be validated before integration into routine patient testing. BD Vacutainers are commonly used in clinical laboratories compared to other blood collection tubes, while V-PRO tubes have recently been introduced to the market without prior laboratory validation. This study compares V-PRO tubes to BD Vacutainers to assess the validity of using V-PRO tubes for blood testing. MATERIALS AND

methodsBlood samples were collected simultaneously into two different brands of tubes (V-PRO and BD) from 60 subjects. A standardized procedure was employed for sample collection, and analysis. A total of 28 chemistry tests and 20 immunoassays were analyzed using Abbott instruments, while high-performance liquid chromatography was used for testing glycated hemoglobin. The biases of V-PRO compared to BD were evaluated against current desirable quality specifications for bias derived from biological variation. For technical validation, a designated survey was distributed to various institutes using both tube types in their laboratories.

resultsThe V-PRO tube exhibited biases exceeding the desirable limits for CO

conclusionsLaboratories currently using BD vacutainers should exercise caution if they intend to perform chemistry and immunoassay tests with V-PRO tubes. The technical validation outcomes for V-PRO were not acceptable due to significant faults identified in comparison to BD Vacutainer.

Indexed as

Blood Chemical AnalysisBlood Specimen CollectionHumansImmunoassayReproducibility of ResultsbloodtubevacutainervalidationV‐PRO

Identifiers

PMID40038231
PMCPMC11937167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.